Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
91.39
-1.81 (-1.94%)
May 14, 2025, 2:45 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 24.67 billion as of May 13, 2025. Its market cap has increased by 79.96% in one year.
Market Cap
24.67B
Enterprise Value
23.54B
Revenue
593.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
91.39
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 24.67B, an increase of 37.81%. That is a compound annual growth rate of 6.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 14, 2025 | 24.14B | 46.33% |
Dec 31, 2024 | 16.49B | 17.70% |
Dec 29, 2023 | 14.01B | 40.02% |
Dec 30, 2022 | 10.01B | -29.08% |
Dec 31, 2021 | 14.11B | -9.10% |
Dec 31, 2020 | 15.53B | -13.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 325.75B |
Shenzhen Mindray Bio-Medical Electronics | 281.76B |
WuXi AppTec | 170.65B |
Zhangzhou Pientzehuang Pharmaceutical., | 124.60B |
Aier Eye Hospital Group | 121.89B |
Shanghai United Imaging Healthcare | 113.80B |
Sichuan Biokin Pharmaceutical | 106.93B |
Yunnan Baiyao Group Co.,Ltd | 101.81B |